ÂÜÀòÂÒÂ×

Zachary Karl, Ph.D. is the Vice President and Head of Business Development at Invizyne, where Zachary focuses on growth strategies, partnerships, and opportunities in synthetic biology. Previously, Zachary held roles such as Director of Business Development at Ginkgo Bioworks, Founder of Ambedo, and Director of Antigen Development and Production at SAB Biotherapeutics. With a background in biochemistry and molecular biology, Zachary has led various teams and initiatives in the fields of biotechnology and sustainable energy.